Correct measurements in clinical chemistry are of fundamental importance in medicine as a whole and for every individual patient. Traceable measurements are legally required in Europe and are obligatory in many countries for this reason. The methods developed in this project shall be used as reference points for traceability used by clinical test laboratories in Europe for the benefit of the patients and cost reduction in health care.
- METAS is now able to offer SI-traceable standards and calibrations for the ion activity and the concentration (or content) of the main serum electrolyte ions Na+, K+, Mg2+, Ca2+ und Cl- in the physiological range.
- METAS offers SI-traceable standards and calibration of instruments for the concentration (or content) of glucose in serum material as a service.
Currently, internationally accepted standards based on primary methods linking to the clinically active forms of elements are not available. The method developed in the project provide such tools. This comprises reference methods species like doubly charged calcium ions. Such health status markers are essential in diagnosis of critical diseases like e.g. heart attack and depression.
The results can be used to calibrate and compare new and additional measurement systems in the medical diagnostic field. Such new tools will help to improve medical decisions in coherence with the requirements of an evidence based medicine.
Engagement with external bodies and stakeholders
A number of decision makers such as the joint committee for traceability in laboratory medicine (JCTLM), the international federation of clinical chemists (IFCC), the medical diagnostic industry as well as relevant national associations have been informed about the higher order reference standards and procedures developed within the workpackage.
The expected impact in the medical diagnostic field is promising, but cannot yet be quantified. If the IFCC promotes the activity scale similar to pH the medical diagnoses of the electrolyte status will be much better defined.
METAS has applied at JCTLM for the acceptance of new reference measurement procedures. A number of stakeholders from diagnostic instrument manufacturers as well as national associations involved in medical diagnostic have been contacted and the new opportunities were offered and explained. A one day symposium for the regulators and national decision makers in the health field was organised at METAS on 2011-06-06 in order to discuss the current status and future opportunities in the clinical analytical field of Switzerland.
PTB one of our project partners is in contact with MHH (Medizinische Hochschule Hannover) a German leading health clinic for preliminary test measurements for activity of doubly charged ions in comparison with atomic emission spectrometric measurements. A combined flow through measurement system consisting of ISE’s and a pH electrode may show its suitability in a future reference measurement procedure for blood serum.
The two Swiss proficiency testing centres (MQ Zürich and CSCQ Geneva working according to the rules imposed by QUALAB) received reference values for electrolyte concentration values for one such comparison in 2011. Some severe deviations became visible as the consensus values defined did not agree with the SI-traceable reference values using the Rilibäk tolerance limits.
For these analytes traceability was established as required by the IVDD 98/79/EG which is part of the Swiss medical prodcuts ordinance MepV (MepV Art. 4b) and higher order reference standards as well as procedures for their measurement are available for medical diagnostic purposes.
The knowledge gained for glucose measurement was used to calibrate reference measurement instruments for two industrial POCT-instrument manufacturer from abroad.
Traceability of concentration and activity values for certain analytes in serum can now be offered to interested customers from the clinical field as a service.